Status: Not yet recruiting
A Study of BEBT-701 in Patients With Mild to Moderate Hypertension and Elevated Low-Density Lipoprotein Cholesterol(LDL-C)
This Phase I/II clinical trial is designed to evaluate, through a single-dose Phase I segment and a multiple-dose Phase II segment, the safety/tolerability, pharmacokinetic (PK) profile, and pharmacodynamic (PD) characteristics of BEBT-701 administered by subcutaneous injection in patients with mild to moderate hypertension and elevated LDL-C , and to explore its preliminary efficacy.
Participants needed: 340
Trial details
Phase: Phase 1, Phase 2Age: 18-60Biological sex: AllType: InterventionalSponsor: BeBetter Med IncUpdated: Jan 26, 2026Locations: 1
Eligibility criteria
Male or female aged 18 to 60 years (inclusive). [+9]
Any history of severe illness-apart from hypertension and hyperlipidemia-that in... [+27]